Ann arbor
ANN ARBOR, Michigan, December 13, 2011 -
Molecular Imaging, Inc.
ANN ARBOR, Michigan, July 19, 2011 -
Terumo Heart, Inc., a wholly owned subsidiary of Terumo
Corporation, today announced that a patient implanted with the
DuraHeart™ Left Ventricular Assist System (LVAS) has surpassed five
years of support on the mechanical circulatory support device.
ANN ARBOR, Michigan and LONDON, April 13, 2011 - NextGen Group plc (AIM:NGG) is pleased to announce that its US-subsidiary
NextGen Sciences Inc, a leader in biomarker discovery, measurement and
qualification, has launched its plasmabreast25 multiplex protein assay,
targeting breast cancer (www.nextgensciences.com/assays/breast.php)
biomarker discovery and qualification.
ANN ARBOR, Michigan and LONDON, March 16, 2011 - NextGen Group plc (AIM:NGG) is pleased to announce that its
subsidiary NextGen Sciences Inc, a leader in biomarker discovery, measurement
and qualification, has launched its first multiple protein (multiplex) assay,
plasmadiscovery41, for oncology biomarker discovery and qualification.
ANN ARBOR, Michigan, and LONDON, March 9, 2011 - NextGen Group plc (AIM:NGG) is pleased to announce that its
subsidiary NextGen Sciences Inc, a leader in biomarker discovery, measurement
and qualification, has completed a commercial reorganization.
More News
- March 9th Webinar Exposes Communications Network Threats and Explores Security Practices with Bell Canada, Nokia Siemens, Nakina Systems, and Technology Research Institute
- Leading experts address why customers reject most retention campaigns and how top telecom providers save their best customers
- Long-Term Experience With the DuraHeart(TM) Left-Ventricular Assist System Continues to Grow As Another Patient Surpasses Four Years of Support on the Device
- Terumo Heart Names Tom Gould and Mark Bullivant to Senior Management Positions in Left Ventricular Assist Device Market
- Terumo Heart, Inc. Reaches Clinical Milestone as the 100th Patient Worldwide Receives the DuraHeart(TM) Left Ventricular Assist System
- Study Data Show Positive European Experience With DuraHeart Left Ventricular Assist Device for Advanced Stage Heart Failure Patients
